Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 4 clients • 6 examiners • 6 art units • 0 of 6 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
Hunt IP Law has 6 pending office actions in Biotechnology & Pharmaceuticals and 235 career applications. Its resolved allowance rate is 67.67%, with an average of 2.71 office actions per allowance.
The profile provides a smaller application history together with current docket activity in biotechnology and pharmaceuticals. The allowance rate supplies an outcome measure, while the office-action average shows the response activity associated with allowances. Practitioners should consider both when reviewing prosecution performance, while using the pending figure for immediate workload planning.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (33%) |
| Multi-statute (no §101) | 3 (50%) |
| No statute on record | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BORI, IBRAHIM D | 1 | 43.9% | +39.0% |
| BYRNES, DAVID R | 1 | 78.2% | +20.9% |
| KRUSE, DAVID H | 1 | 81.4% | +9.6% |
| SITTON, JEHANNE SOUAYA | 1 | 53.2% | +47.5% |
| FETTEROLF, BRANDON J | 1 | 51.6% | +18.5% |
| SASAN, ARADHANA | 1 | 64.6% | +26.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18000918 | HEMP SPROUT PRODUCTS AND METHODS FOR PRODUCING SAME | SASAN, ARADHANA | 126d overdue |
| 18409352 | CANNABIS PLANT NAMED 'CK2015' | KRUSE, DAVID H | 66d overdue |
| 18336359 | METHOD FOR RAPIDLY AND ACCURATELY DETECTING SARS-CoV-2 NUCLEIC ACID | SITTON, JEHANNE SOUAYA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18000918 | HEMP SPROUT PRODUCTS AND METHODS FOR PRODUCING SAME | SASAN, ARADHANA | 126d overdue |
| 18750843 | HIGH POTENCY EMULSIONS | BORI, IBRAHIM D | 9d overdue |
| 18041015 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALS | FETTEROLF, BRANDON J | 3d overdue |
| 18409264 | CANNABIS PLANT NAMED 'BF2014' | BYRNES, DAVID R | — |
| 18336359 | METHOD FOR RAPIDLY AND ACCURATELY DETECTING SARS-CoV-2 NUCLEIC ACID | SITTON, JEHANNE SOUAYA | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Cbiotix, LLC | 2 |
| CReDO Science, LLC | 2 |
| Vertosa Inc. | 1 |
| Colorado Genomics LLC | 1 |
| Art Unit | Apps |
|---|---|
| 1629 | 1 |
| 1662 | 1 |
| 1663 | 1 |
| 1682 | 1 |
| 1626 | 1 |
| 1615 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18750843 | HIGH POTENCY EMULSIONS | Vertosa Inc. | BORI, IBRAHIM D | 1629 | — | Final Rejection | 9d overdue | Pending | Jun 21, 2024 |
| 18409264 | CANNABIS PLANT NAMED 'BF2014' | Cbiotix, LLC | BYRNES, DAVID R | 1662 | §103 | Final Rejection | — | Pending | Jan 10, 2024 |
| 18409352 | CANNABIS PLANT NAMED 'CK2015' | Cbiotix, LLC | KRUSE, DAVID H | 1663 | §103§112 | Final Rejection | 66d overdue | Pending | Jan 10, 2024 |
| 18336359 | METHOD FOR RAPIDLY AND ACCURATELY DETECTING SARS-CoV-2 NUCLEIC ACID | Colorado Genomics LLC | SITTON, JEHANNE SOUAYA | 1682 | §103§112 | Non-Final OA | — | Pending | Jun 16, 2023 |
| 18041015 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALS | Credo Science, LLC | FETTEROLF, BRANDON J | 1626 | §103 | Non-Final OA | 3d overdue | Pending | Feb 08, 2023 |
| 18000918 | HEMP SPROUT PRODUCTS AND METHODS FOR PRODUCING SAME | Credo Science, LLC | SASAN, ARADHANA | 1615 | §103§112 | Final Rejection | 126d overdue | Pending | Dec 06, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial67.7% of resolved applications prosecuted by Hunt Ip Law were allowed, across 235 applications in USPTO records.
2.71 office actions per allowed application on average.
6 pending office actions as of October 2026, for 4 clients, before 6 examiners in 6 art units.
